Goeroptics Showcases Industry-Leading 50° FoV SiC Waveguide and XR Optical Innovations at SPIE

Goeroptics Showcases Industry-Leading 50° FoV SiC Waveguide and XR Optical Innovations at SPIE

SAN FRANCISCO, Jan. 23, 2026 /PRNewswire/ -- Goeroptics, a world's leading AR&MR solution provider, unveiled a suite of advanced XR optical solutions at SPIE AR|VR|MR 2026. The company debut its latest AR flagship product, the F50Se — a 50° FoV...

Aeronero Receives Frost & Sullivan's 2025 Global Transformational Innovation Leadership Recognition for Pioneering Advancements in Atmospheric Water Generation

Aeronero Receives Frost & Sullivan's 2025 Global Transformational Innovation Leadership Recognition for Pioneering Advancements in Atmospheric Water Generation

Recognized for redefining water security through breakthrough hybrid atmospheric water generation technology and sustainable innovation SAN ANTONIO, Jan. 13, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Aeronero has been...

Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib (LNK01001) in Rheumatoid Arthritis

Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib (LNK01001) in Rheumatoid Arthritis

HANGZHOU, China, SHANGHAI and BOSTON, Jan. 12, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical stage innovative drug development company focused on developing innovative therapies...

Supermicro Announces Intelligent In-Store Retail Solutions in Collaboration with a Broad Range of Industry Partners

Supermicro Announces Intelligent In-Store Retail Solutions in Collaboration with a Broad Range of Industry Partners

Innovative technologies enable retailers to implement intelligent stores at scale to deliver smarter, more responsive shopping experiences Industry partners to display production-ready AI solutions for loss prevention, digital twins, AI agents,...

Salcomp's Debut on CES 2026

Salcomp's Debut on CES 2026

Reconfiguration of Full-stack Capabilities to Restructure Embodied Intelligent Ecosystem LAS VEGAS, Jan. 8, 2026 /PRNewswire/ -- Salcomp, the leading global intelligent manufacturing enterprise, is showcasing its complete humanoid robot technology...

Hisense Showcases a Full-Scenario Smart Home Ecosystem at CES 2026

Hisense Showcases a Full-Scenario Smart Home Ecosystem at CES 2026

LAS VEGAS, Jan. 7, 2026 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, showcases a full-scenario smart home ecosystem at CES 2026, demonstrating how advanced display technologies and AI-powered home...

MICROIP Highlights AIVO Edge AI Platform at CES 2026, Enabling Scalable Deployment Across Transportation Security, Agriculture, and Autonomous Systems

MICROIP Highlights AIVO Edge AI Platform at CES 2026, Enabling Scalable Deployment Across Transportation Security, Agriculture, and Autonomous Systems

LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- MICROIP Inc., a Taiwan-based provider of ASIC design services and AI software solutions, today showcased its AIVO (AI Vision Operation) Edge AI platform at CES 2026 in Las Vegas. Exhibiting at the AI...

SKF achieves prestigious CDP 'A' Score for Environmental Leadership

SKF achieves prestigious CDP 'A' Score for Environmental Leadership

GOTHENBURG, Sweden, Dec. 22, 2025 /PRNewswire/ -- For the third consecutive year SKF has earned an 'A' score in the category Climate Change from CDP, the global non-profit leading environmental disclosure. In 2025 nearly 20,000 companies were scored...

Avnet and AMD Showcase Scalable AI Solutions to Accelerate Australia's Tech Leadership

Avnet and AMD Showcase Scalable AI Solutions to Accelerate Australia's Tech Leadership

SYDNEY, Dec. 15, 2025 /PRNewswire/ -- Avnet and AMD have wrapped up the inaugural 'AMD on Wheels' national roadshow, bringing cutting-edge AI and high-performance computing solutions to innovation hubs across Australia. The initiative reaffirmed the...

Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+

Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+

First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters Reinvigoration of immune system + turning cold tumors hot Preliminary ex-vivo data in HER2+ patients...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • menu
    menu